Advances in 3D neural, vascular and neurovascular models for drug testing and regenerative medicine

last updated: 2020-12-21
ProjectFROnTHERA :: publications list
TitleAdvances in 3D neural, vascular and neurovascular models for drug testing and regenerative medicine
Publication TypeReview Paper
Year of Publication2020
AuthorsFernandes D. C., Reis R. L., and Oliveira J. M.
Abstract Text

Clinical trials continue to fall short regarding drugs to effectively treat brain-affecting diseases. Although there are many causes of these shortcomings, the most relevant are the inability of most therapeutic agents to cross the blood–brain barrier (BBB) and the failure to translate effects from animal models to patients. In this review, we analyze the most recent developments in BBB, neural, and neurovascular models, analyzing their impact on the drug development process by considering their quantitative and phenotypical characterization. We offer a perspective of the state-of-the-art of the models that could revolutionize the pharmaceutical industry.

JournalDrug Discovery Today
Volume20
IssueS1359-6446
Pagination30474-8
Date Published2020-11-10
PublisherElsevier
ISSN1359-6446
DOI10.1016/j.drudis.2020.11.009
KeywordsDrug development, Neural Models, Neurovascular models
RightsopenAccess
Peer reviewedyes
Statuspublished

Back to top